The failure to detect changes in chemotherapy-induced peripheral neuropathy in adult NMNAT2+/- mice cannot be attributed to compensatory changes in other NMNAT isoforms, NMNAT enzyme activity or changes in MAP2 or neurofilament levels in adult DRG. This evidence concerns the gene NMNAT1 and peripheral neuropathy.